OssDsign AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft for dual bone formation pathways through fusion mass. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
Market Cap & Net Worth: OssDsign AB (OSSD)
OssDsign AB (ST:OSSD) has a market capitalization of $60.65 Million (Skr680.35 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #21714 globally and #247 in its home market, demonstrating a 6.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OssDsign AB's stock price Skr6.15 by its total outstanding shares 110625913 (110.63 Million).
OssDsign AB Market Cap History: 2019 to 2026
OssDsign AB's market capitalization history from 2019 to 2026. Data shows change from $128.15 Million to $60.65 Million (-14.13% CAGR).
Index Memberships
OssDsign AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$4.63 Billion | 0.98% | #25 of 281 |
Weight: OssDsign AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
OssDsign AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OssDsign AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.62x
OssDsign AB's market cap is 0.62 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $128.15 Million | $16.87 Million | -$84.25 Million | 7.60x | N/A |
| 2020 | $118.10 Million | $24.87 Million | -$84.59 Million | 4.75x | N/A |
| 2021 | $85.79 Million | $31.73 Million | -$93.92 Million | 2.70x | N/A |
| 2022 | $57.39 Million | $56.98 Million | -$99.39 Million | 1.01x | N/A |
| 2023 | $78.89 Million | $112.16 Million | -$130.49 Million | 0.70x | N/A |
| 2024 | $97.23 Million | $133.94 Million | -$49.66 Million | 0.73x | N/A |
| 2025 | $111.83 Million | $180.16 Million | -$50.99 Million | 0.62x | N/A |
Competitor Companies of OSSD by Market Capitalization
Companies near OssDsign AB in the global market cap rankings as of March 18, 2026.
Key companies related to OssDsign AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
OssDsign AB Historical Marketcap From 2019 to 2026
Between 2019 and today, OssDsign AB's market cap moved from $128.15 Million to $ 60.65 Million, with a yearly change of -14.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr60.65 Million | -45.77% |
| 2025 | Skr111.83 Million | +15.01% |
| 2024 | Skr97.23 Million | +23.25% |
| 2023 | Skr78.89 Million | +37.46% |
| 2022 | Skr57.39 Million | -33.10% |
| 2021 | Skr85.79 Million | -27.35% |
| 2020 | Skr118.10 Million | -7.85% |
| 2019 | Skr128.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OssDsign AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $60.65 Million USD |
| MoneyControl | $60.65 Million USD |
| MarketWatch | $60.65 Million USD |
| marketcap.company | $60.65 Million USD |
| Reuters | $60.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.